Results 101 to 110 of about 1,106 (130)

Fabry Disease: A Focus on the Role of Oxidative Stress. [PDF]

Antioxidants (Basel)
Rydzek J, Muzyka A, Majcherczyk K, Soczyńska J, Gawełczyk W, Żołyniak M, Woźniak S.   +6 more
europepmc   +1 more source

Persistent troponin elevation in the heart of Fabry disease due to coronary microvascular dysfunction. [PDF]

SAGE Open Med Case Rep
Tan C, Higgins MD, Zhang Z, Hiskens M.
europepmc   +1 more source

A rapid method to reduce drug interferences for antibody measurements in pegunigalsidase alfa-treated patients with Fabry disease. [PDF]

Front Immunol
Lenders M, Rudolph E, Rudnicki M, Cybulla M, Brand E.   +4 more
europepmc   +1 more source

Population Pharmacokinetic Modeling for the Iminosugar Lucerastat Supports Dose Adaptation in Patients With Fabry Disease and Moderate to Severe Renal Function Impairment. [PDF]

J Clin Pharmacol
Brussee JM, Dingemanse J, Lott D, Berger B, Frey A, Krause A.   +5 more
europepmc   +1 more source

Use of nonsteroidal mineralocorticoid receptor antagonist in chronic kidney disease: A case report of a patient with Fabry disease in his mid-20s. [PDF]

J Int Med Res
Tian GQ, Yang P, Liao ZC, Xiao W, Li J, Song B.   +5 more
europepmc   +1 more source

Anderson-Fabry Disease: An Overview of Current Diagnosis, Arrhythmic Risk Stratification, and Therapeutic Strategies. [PDF]

Diagnostics (Basel)
Tognola C, Ruzzenenti G, Maloberti A, Varrenti M, Mazzone P, Giannattasio C, Guarracini F.   +6 more
europepmc   +1 more source

Functional and histopathologic correlation in the fabry nephropathy with N215S genotype. [PDF]

Orphanet J Rare Dis
Mignani R, Berti GM, Vischini G, Di Costanzo R, Ciurli F, Vetrano D, Biagini E, Serratore S, Fabbrizio B, Pasquinelli G, La Manna G, Capelli I.   +11 more
europepmc   +1 more source

Trends in Formulary Coverage of Nonprotected Class Drugs Granted FDA Accelerated Approval.

JAMA Netw Open
Jazowski SA, Dusetzina SB.
europepmc   +1 more source

Influence of Treatment Effect Modifiers in Fabry Disease: A Systematic Literature Review. [PDF]

Adv Ther
Azimpour K, Tordoff-Gibson C, Dorling P, Koulinska I, Kunduri S, Laliman-Khara V, Forsythe A.   +6 more
europepmc   +1 more source

Beyond Wall Thickness: Phenotype-Guided Diagnosis of Left Ventricular Hypertrophy. [PDF]

JACC Asia
Jin W, Chen Y, Zhang Q, Peng D, Wu Z, Bu J, Huo Y, Ge J, Dong Y, Yang J.   +9 more
europepmc   +1 more source